Researcher.Life Logo

Oxidative Medicine and Cellular Longevity : Impact Factor & More

eISSN: 1942-0994pISSN: 1942-0900

Key Metrics

CiteScore
9.3
Eigenfactor
0.01 - 0.05
Impact Factor
5 - 10
Scite Index
0.95 5-Year SI
SJR
Q1Aging
SNIP
1.6
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Oxidative Medicine and Cellular Longevity

Oxidative Medicine and Cellular Longevity Journal Specifications

Overview
Publisher HINDAWI LTD
Language English
Frequency Continuous publication
General Details
LanguageEnglish
FrequencyContinuous publication
Publication Start Year2008
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Oxidative Medicine and Cellular Longevity ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Oxidative Medicine and Cellular Longevity

Correction to “Chronic Cerebral Hypoperfusion Aggravates Parkinson’s Disease Dementia‐Like Symptoms and Pathology in 6‐OHDA‐Lesioned Rat through Interfering with Sphingolipid Metabolism”
  • 5 Apr 2026
  • Oxidative Medicine and Cellular Longevity
Correction to “Metformin Reduces the Senescence of Renal Tubular Epithelial Cells in Diabetic Nephropathy via the MBNL1/miR‐130a‐3p/STAT3 Pathway”
  • 1 Apr 2026
  • Oxidative Medicine and Cellular Longevity
Nrf2 Activation in Inflammatory Diseases: A Review of Natural and Synthetic Modulators
  • 10 Mar 2026
  • Oxidative Medicine and Cellular Longevity
Correction to “Neonatal Hyperoxia Downregulates Claudin‐4, Occludin, and ZO‐1 Expression in Rat Kidney Accompanied by Impaired Proximal Tubular Development”
  • 12 Feb 2026
  • Oxidative Medicine and Cellular Longevity
RETRACTION: A Novel Molecular Mechanism of IKKε‐Mediated Akt/mTOR Inhibition in the Cardiomyocyte Autophagy after Myocardial Infarction
  • 3 Feb 2026
  • Oxidative Medicine and Cellular Longevity
Oxidative and Inflammatory Mechanisms Induced by Intermittent Hypoxia Leading to Vascular Alterations in Rodents: A Systematic Review and Meta‐Analysis
  • 14 Jan 2026
  • Oxidative Medicine and Cellular Longevity
Correction to “Chronic Cerebral Hypoperfusion Aggravates Parkinson’s Disease Dementia‐Like Symptoms and Pathology in 6‐OHDA‐Lesioned Rat through Interfering with Sphingolipid Metabolism”
  • 5 Apr 2026
  • Oxidative Medicine and Cellular Longevity
Correction to “Metformin Reduces the Senescence of Renal Tubular Epithelial Cells in Diabetic Nephropathy via the MBNL1/miR‐130a‐3p/STAT3 Pathway”
  • 1 Apr 2026
  • Oxidative Medicine and Cellular Longevity
Nrf2 Activation in Inflammatory Diseases: A Review of Natural and Synthetic Modulators
  • 10 Mar 2026
  • Oxidative Medicine and Cellular Longevity
Correction to “Neonatal Hyperoxia Downregulates Claudin‐4, Occludin, and ZO‐1 Expression in Rat Kidney Accompanied by Impaired Proximal Tubular Development”
  • 12 Feb 2026
  • Oxidative Medicine and Cellular Longevity
RETRACTION: A Novel Molecular Mechanism of IKKε‐Mediated Akt/mTOR Inhibition in the Cardiomyocyte Autophagy after Myocardial Infarction
  • 3 Feb 2026
  • Oxidative Medicine and Cellular Longevity
Oxidative and Inflammatory Mechanisms Induced by Intermittent Hypoxia Leading to Vascular Alterations in Rodents: A Systematic Review and Meta‐Analysis
  • 14 Jan 2026
  • Oxidative Medicine and Cellular Longevity

FAQs on Oxidative Medicine and Cellular Longevity